MCID: PRP009
MIFTS: 38

Peripartum Cardiomyopathy malady

Rare diseases, Reproductive diseases, Cardiovascular diseases, Muscle diseases categories

Aliases & Classifications for Peripartum Cardiomyopathy

About this section
Sources:
10Disease Ontology, 45NIH Rare Diseases, 12DISEASES, 51Orphanet, 65UMLS, 29ICD9CM, 28ICD10 via Orphanet, 66UMLS via Orphanet
See all sources

Aliases & Descriptions for Peripartum Cardiomyopathy:

Name: Peripartum Cardiomyopathy 10 45 12 51 65
Postpartum Cardiomyopathy 45 51 65
Peripartum Cardiomyopathy, Postpartum Condition or Complication 65
Peripartum Cardiomyopathy, Antepartum Condition or Complication 65
 
Postpartum Peripartum Cardiomyopathy 10
Antepartum Peripartum Cardiomyopathy 10
Postpartum Dilated Cardiomyopathy 65
Meadows' Syndrome 45


Classifications:



Characteristics (Orphanet epidemiological data):

51
peripartum cardiomyopathy:
Age of onset: Adult


External Ids:

Disease Ontology10 DOID:9997
ICD9CM29 674.5
Orphanet51 563
ICD10 via Orphanet28 O90.3
UMLS via Orphanet66 C0269972, C0877208

Summaries for Peripartum Cardiomyopathy

About this section
Wikipedia:68 Peripartum cardiomyopathy (PPCM) is a form of dilated cardiomyopathy that is defined as a deterioration... more...

MalaCards based summary: Peripartum Cardiomyopathy, also known as postpartum cardiomyopathy, is related to cardiomyopathy and dilated cardiomyopathy. An important gene associated with Peripartum Cardiomyopathy is PRL (Prolactin), and among its related pathways are Antiarrhythmic Pathway, Pharmacodynamics and Hypertrophic cardiomyopathy (HCM). Affiliated tissues include heart, cardiac myocytes and testes, and related mouse phenotype muscle.

Related Diseases for Peripartum Cardiomyopathy

About this section

Diseases related to Peripartum Cardiomyopathy via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 89)
idRelated DiseaseScoreTop Affiliating Genes
1cardiomyopathy11.5
2dilated cardiomyopathy10.5
3eclampsia10.4
4pre-eclampsia10.4
5left ventricular noncompaction10.4
6congestive heart failure10.3
7pulmonary edema10.3
8cardiac arrest10.3
9myocarditis10.3
10pulmonary embolism10.3
11cardiogenic shock10.3
12myocardial infarction10.3
13coronary heart disease 210.3
14noonan syndrome 110.3
15congenital heart disease10.3
16ventricular septal defect10.3
17familial dilated cardiomyopathy10.3
18ainhum10.2DRD2, PRL
19clear cell adenoma10.2DRD2, PRL
20brill-zinsser disease10.2DRD2, PRL
21schizoid personality disorder10.2DRD2, PRL
22carotid artery occlusion10.2DRD2, PRL
23tricuspid valve stenosis10.1DRD2, PRL
24substance dependence10.1DRD2, PRL
25pertussis10.1DRD2, PRL
26hyperprolactinemia10.1DRD2, PRL
27x-linked cleft palate and ankyloglossia10.1MYH7, TTN
28schizophrenia10.1
29systemic lupus erythematosus10.1
30obesity10.1
31anemia, sideroblastic, pyridoxine-refractory, autosomal recessive10.1
32coronary heart disease 510.1
33wolff-parkinson-white syndrome10.1
34coronary heart disease 810.1
35coronary heart disease 610.1
36pick disease10.1
37coronary heart disease 310.1
38duchenne muscular dystrophy10.1
39pulmonary hypertension10.1
40acute myocardial infarction10.1
41hepatitis10.1
42myasthenia gravis10.1
43splenic infarction10.1
44hellp syndrome10.1
45paranoid schizophrenia10.1
46graves' disease10.1
47diastolic heart failure10.1
48cerebritis10.1
49atrioventricular block10.1
50autoimmune polyendocrine syndrome10.1

Graphical network of the top 20 diseases related to Peripartum Cardiomyopathy:



Diseases related to peripartum cardiomyopathy

Symptoms for Peripartum Cardiomyopathy

About this section

Drugs & Therapeutics for Peripartum Cardiomyopathy

About this section

Drugs for Peripartum Cardiomyopathy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 7)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Bromocriptineapproved, investigationalPhase 3, Phase 22725614-03-331101
Synonyms:
(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman
(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione
(5'alpha)-2-bromo-12'-hydroxy-5'-(2-methylpropyl)-2'-(propan-2-yl)-3',6',18-trioxoergotaman
(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman
(6aR,9R)-5-Bromo-N-((2R,5S,10aS,10bS)-10b-hydroxy-5-isobutyl-2-isopropyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-alpha-(2-methylpropyl)ergotamin-3',6',18-trione
2-Bromo-alpha-ergocryptine
2-Bromo-alpha-ergokryptin
2-Bromo-alpha-ergokryptine
2-Bromoergocryptine Methanesulfonate
2-Bromoergokryptine
2-bromo-α-ergocryptine
2-bromo-α-ergokryptin
2-bromo-α-ergokryptine
22260-51-1 (mesylate (salt))
25614-03-3
AC-13601
AC1L1KXS
AC1Q2716
Alti-Bromocriptine
Apo-Bromocriptine
BIDD:GT0464
BPBio1_001131
BRD-K14496212-001-01-1
Bagren
Biomol-NT_000005
Bromergocryptine
Bromocriptin
Bromocriptina
Bromocriptina [INN-Spanish]
Bromocriptine
Bromocriptine (USAN/INN)
Bromocriptine Methanesulfonate
Bromocriptine [BAN]
Bromocriptine [USAN:BAN:INN]
 
Bromocriptine methanesulfonate
Bromocriptinum
Bromocriptinum [INN-Latin]
Bromocryptin
Bromocryptine
Bromoergocriptine
Bromoergocryptine
C06856
C32H40BrN5O5
CB-154
CCRIS 3244
CHEBI:3181
CHEMBL493
CID31101
Cycloset
D03165
DB01200
EINECS 247-128-5
Ergocryptine, 2-bromo- (8CI)
Ergoset
LS-64540
Lopac0_000171
MolPort-002-512-064
NCGC00024584-04
NCI60_001365
NSC169774
PDSP2_001500
Parlodel
Parlodel Snaptabs
Prestwick0_000121
Prestwick1_000121
Prestwick2_000121
SPBio_002101
UNII-3A64E3G5ZO
bromocriptine
nchembio873-comp18
2
DopamineapprovedPhase 3, Phase 2281462-31-7, 51-61-6681
Synonyms:
(3H)-Dopamine
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
ASL 279
BIDD:ER0506
BPBio1_001123
BSPBio_001932
Biomol-NT_000001
C03758
CHEBI:18243
CHEMBL59
CID681
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine Hcl
Dopamine Hydrochloride
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
Hydroxytyramine
IDI1_000780
IP 498
Intropin
Intropin [*hydrochloride*]
 
KBio1_000780
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
LS-159
Lopac-H-8502
Lopac0_000586
Medopa (TN)
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
SPECTRUM1505155
ST048774
STK301601
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Spectrum_001012
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
cMAP_000036
cMAP_000065
dopamine
hydroxytyramine
intropin
m-Hydroxytyramine hydrochloride
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
3
Heparinapproved, investigationalPhase 36729005-49-6772, 46507594
Synonyms:
101921-26-0
102-94-3
102785-31-9
104521-37-1
11078-24-3
11129-39-8
12656-11-0
2-o-sulfohexopyranuronosyl-(1->4)-2-deoxy-3-o-sulfo-2-(sulfoamino)hexopyranosyl-(1->4)-2-o-sulfohexopyranuronosyl-(1->4)-2-acetamido-2-deoxy-6-o-sulfohexopyranose
37324-73-5
6-[6-[6-[5-acetamido-4,6-dihydroxy-2-(sulfooxymethyl)oxan-3-yl]oxy-2-carboxy-4-hydroxy-5-sulfooxyoxan-3-yl]oxy-2-(hydroxymethyl)-5-(sulfoamino)-4-sulfooxyoxan-3-yl]oxy-3,4-dihydroxy-5-sulfooxyoxane-2-carboxylic acid
9041-08-1
9045-22-1
9075-96-1
913079-23-9
91449-79-5
AC1L19ZN
AC1L1ROY
ALFA 87-120
ALFA 87-163
ALFA 87-198
ALFA 87-81
ALFA 88-247
AR-1E4539
Allocinnamic acid
Ardeparin
Ardeparin sodium
Arteven
Bemiparin
Bemiparin sodium
CID772
CID8784
CY 216
Calciparine
Certoparin
Clexane
Clivarin
Clivarine
Cy 222
D006495
D017984
DB00407
DB01225
Dalteparin
Dalteparin sodium
Depo-Heparin
EINECS 232-681-7
EMT 966
EMT 967
EMT-966
EMT-967
EMT966
EMT967
Enoxaparin
Enoxaparin sodium
Enoxaparine
Eparina
Eparina [DCIT]
FR 860
Fluxum
Fragmin A
Fragmin B
Fragmin IV
Fraxiparin
H 2149
HSDB 3094
Hed-heparin
Hep Flush Kit in plastic container
Hep-Lock
Hep-Lock U/P
Hep-lock
Heparin
Heparin CY 216
Heparin Lock Flush
Heparin Lock Flush in plastic container
Heparin Lock Flush preservative free
Heparin Lock Flush preservative free in plastic container
Heparin Sodium
Heparin natrium
Heparin sodium
Heparin sodium 1,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 1,000 units in dextrose 5% in plastic container
Heparin sodium 1,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 10,000 units in dextrose 5%
Heparin sodium 10,000 units in dextrose 5% in plastic container
Heparin sodium 10,000 units in sodium chloride 0.45%
Heparin sodium 10,000 units in sodium chloride 0.9%
Heparin sodium 12,500 units in dextrose 5%
Heparin sodium 12,500 units in dextrose 5% in plastic container
Heparin sodium 12,500 units in sodium chloride 0.45% in plastic container
Heparin sodium 12,500 units in sodium chloride 0.9%
Heparin sodium 2,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 2,000 units in dextrose 5% in plastic container
Heparin sodium 2,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 20,000 units and dextrose 5% in plastic container
Heparin sodium 20,000 units in dextrose 5% in plastic container
Heparin sodium 25,000 units and dextrose 5% in plastic container
 
Heparin sodium 25,000 units in dextrose 5%
Heparin sodium 25,000 units in dextrose 5% in plastic container
Heparin sodium 25,000 units in sodium chloride 0.45% in plastic container
Heparin sodium 25,000 units in sodium chloride 0.9%
Heparin sodium 25,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 5,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 5,000 units in dextrose 5% in plastic container
Heparin sodium 5,000 units in sodium chloride 0.45%
Heparin sodium 5,000 units in sodium chloride 0.9%
Heparin sodium 5,000 units in sodium chloride 0.9% in plastic container
Heparin sodium in plastic container
Heparin sodium preservative Free
Heparin sulfate
Heparin sulphate
Heparin, Low Molecular Weight
Heparin, Low-Molecular-Weight
Heparin, sodium salt
Heparina
Heparina [INN-Spanish]
Heparinate
Heparine
Heparine [INN-French]
Heparinic acid
Heparinsodiumsalt
Heparinum
Heparinum [INN-Latin]
Heparinum natricum
Hepathrom
Hepflush-10
Inno-Hep
Innohep
Isocinnamic acid
KB 101
Kabi 2165
LHN 1
LMWH
Lioton 1000
Lipo-hepin
Liquaemin
Liquaemin Lock Flush
Liquaemin Sodium
Liquaemin sodium preservative free
Liquemin
Logiparin
Lovenox
Lovenox HP
Low Molecular Weight Heparin
Low molecular weight heparin
Low molecular weight heparin sodium
Low-Molecular-Weight Heparin
Minolteparin sodium
MolPort-003-760-257
Multiparin
NSC174025
Nadroparin
Nadroparine
Novoheparin
OP 386
OP 622
Octaparin
PK 10,169
PK-10,169
PK-10169
PK10,169
PK10169
Pabyrin
Panheprin
Parnaparin
Parnaparin sodium
Parvoparin
Pularin
Reviparin
Reviparin sodium
Ro 11
Sandoparin
Sodium acid heparin
Sodium heparin
Sodium heparinate
Subeparin
Sublingula
Thromboliquine
Tinzaparin
Tinzaparin sodium
Triofiban
UNII-12M44VTJ7B
UNII-3S182ET3UA
UNII-E47C0NF7LV
UNII-T2410KM04A
UNII-ZZ45AB24CA
Vetren
Vitrum AB
WY 90493RD
alpha-Heparin
cis-.beta.-Carboxystyrene
cis-Cinnamic acid
enoxaparin
heparin
4
DalteparinapprovedPhase 32659041-08-1
Synonyms:
Daltepariininatrium
Dalteparin Sodyum
Dalteparin sodium
Dalteparin sodná sůl
Dalteparin-nátrium
Dalteparina sódica
 
Dalteparinnatrium
Dalteparino natrio druska
Dalteparinum Natricum
Dalteparyna sodowa
Daltéparine sodique
Fragmin
Heparin Fragment KABI 2165
Tedelparin
5Dopamine AgonistsPhase 3, Phase 2476
6Heparin, Low-Molecular-WeightPhase 3269
7calcium heparinPhase 3672

Interventional clinical trials:

idNameStatusNCT IDPhase
1Bromocriptine in the Treatment of Peripartum CardiomyopathyNot yet recruitingNCT02590601Phase 3
2Effect of Bromocriptine on Left Ventricular Function in Women With Peripartum CardiomyopathyRecruitingNCT00998556Phase 2
3Investigation in Pregnancy Associate CardiomyopathyCompletedNCT01085955
4Registry and Survey of Women With Pregnancy Related CardiomyopathyRecruitingNCT00273637
5The Study of Cardiovascular Outcomes in Women With Preeclampsia Using Echocardiography: The SCOPE StudyRecruitingNCT02357667

Search NIH Clinical Center for Peripartum Cardiomyopathy

Genetic Tests for Peripartum Cardiomyopathy

About this section

Anatomical Context for Peripartum Cardiomyopathy

About this section

MalaCards organs/tissues related to Peripartum Cardiomyopathy:

33
Heart, Cardiac myocytes, Testes, Liver, Brain, Lung

Animal Models for Peripartum Cardiomyopathy or affiliated genes

About this section

MGI Mouse Phenotypes related to Peripartum Cardiomyopathy:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053698.4ADRB1, DRD2, SCN5A, TTN

Publications for Peripartum Cardiomyopathy

About this section

Articles related to Peripartum Cardiomyopathy:

(show top 50)    (show all 488)
idTitleAuthorsYear
1
Peripartum cardiomyopathy in the ED. (25959842)
2015
2
Improving outcomes in peripartum cardiomyopathy. (25927492)
2015
3
Peripartum cardiomyopathy associated with triplet pregnancy. (25163089)
2014
4
Titin gene mutations are common in families with both peripartum cardiomyopathy and dilated cardiomyopathy. (24558114)
2014
5
Peripartum cardiomyopathy: Euro Observational Research Program. (25007941)
2014
6
Delayed peripartum cardiomyopathy after emergency cesarean section. (23560202)
2013
7
Peripartum cardiomyopathy: population-based birth prevalence and 7-year mortality. (23635700)
2013
8
Cardiac arrest precipitated by fluid challenge in a patient with unrecognised peripartum cardiomyopathy. (23259894)
2013
9
Is Tako-tsubo syndrome in the postpartum period a clinical entity different from peripartum cardiomyopathy? (23519095)
2013
10
Electrophysiological mapping and radiofrequency catheter ablation for ventricular tachycardia in a patient with peripartum cardiomyopathy. (24102817)
2013
11
Peripartum cardiomyopathy in an elderly patient with in-vitro fertilization pregnancy. (23029752)
2012
12
The life-changing impact of peripartum cardiomyopathy: an analysis of online postings. (22739480)
2012
13
Is hypertensive disorder a unique risk factor for peripartum cardiomyopathy and pregnancy-associated cardiomyopathy? (21727752)
2011
14
Pregnancy and subsequent pregnancy outcomes in peripartum cardiomyopathy. (21114580)
2011
15
Anesthetic management of a repeat cesarean section in a parturient with severe peripartum cardiomyopathy requiring ECMO in a previous pregnancy: a case report. (22490455)
2011
16
Low dose spinal anesthesia for peripartum cardiomyopathy. (22096304)
2011
17
Value of cardiac MRI in peripartum cardiomyopathy. (21624795)
2011
18
Rapid recovery from peripartum cardiomyopathy after inhibition of prolactin. (20934224)
2011
19
An update on peripartum cardiomyopathy. (21932958)
2011
20
Different characteristics of peripartum cardiomyopathy between patients complicated with and without hypertensive disorders. -Results from the Japanese Nationwide survey of peripartum cardiomyopathy-. (21617320)
2011
21
Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. (20308616)
2010
22
Peripartum cardiomyopathy. (20502425)
2010
23
Peripartum cardiomyopathy may also present as "fulminant right ventricular myocarditis". (21036307)
2010
24
Recovery from severe heart failure following peripartum cardiomyopathy. (19036370)
2009
25
Peripartum cardiomyopathy: prognostic factors for long-term maternal outcome. (18722572)
2008
26
Multidisciplinary management of peripartum cardiomyopathy during repeat cesarean delivery: a case report. (19090314)
2008
27
Recovery from peripartum cardiomyopathy after treatment with bromocriptine. (18926768)
2008
28
Peripartum cardiomyopathy. (18467806)
2008
29
Viral infection as a possible trigger for the development of peripartum cardiomyopathy. (17368646)
2007
30
Incidence, mortality, and racial differences in peripartum cardiomyopathy. (17631087)
2007
31
Improved outcomes in peripartum cardiomyopathy with contemporary. (16923422)
2006
32
Peripartum cardiomyopathy. (17203798)
2006
33
Postnatal pre-cordial pain. Pulmonary embolism or peripartum cardiomyopathy. (15496714)
2004
34
Peripartum cardiomyopathy in Nigeria. (12731142)
2003
35
Peripartum cardiomyopathy and thromboembolism; anesthetic management and clinical course of an obese, diabetic patient. (12560308)
2003
36
Peripartum cardiomyopathy presenting as an acute myocardial infarction. (12005001)
2002
37
Pregnancy and peripartum cardiomyopathy. A comparative and prospective study. (12447499)
2002
38
The addition of pentoxifylline to conventional therapy improves outcome in patients with peripartum cardiomyopathy. (12034156)
2002
39
Peripartum Cardiomyopathy. (11696267)
2001
40
Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. (11372007)
2001
41
Peripartum cardiomyopathy: echocardiogram to predict prognosis. (11293339)
2001
42
Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1. (10716473)
2000
43
A modified definition for peripartum cardiomyopathy and prognosis based on echocardiography. (10432149)
1999
44
Peripartum cardiomyopathy: a comprehensive review. (9500508)
1998
45
Peripartum cardiomyopathy: experiences at King Edward VIII Hospital, Durban, South Africa and a review of the literature. (7660481)
1995
46
Peripartum cardiomyopathy presenting as a cardiac arrest at induction of anaesthesia for emergency caesarean section. (7669479)
1995
47
Clinical management of gravid women with peripartum cardiomyopathy. (1945254)
1991
48
Bulimia in a peripartum cardiomyopathy patient. (3562762)
1987
49
Peripartum cardiomyopathy: two case reports and a review. (3547206)
1986
50
Peripartum cardiomyopathy. (3880917)
1985

Variations for Peripartum Cardiomyopathy

About this section

Expression for genes affiliated with Peripartum Cardiomyopathy

About this section
Search GEO for disease gene expression data for Peripartum Cardiomyopathy.

Pathways for genes affiliated with Peripartum Cardiomyopathy

About this section

Pathways related to Peripartum Cardiomyopathy according to GeneCards Suite gene sharing:

idSuper pathways (with members indented)ScoreTop Affiliating Genes
19.4ADRB1, SCN5A
2
Show member pathways
9.1ADRB1, MYH7, TTN
3
Show member pathways
9.0ADRB1, MYH7, SCN5A

GO Terms for genes affiliated with Peripartum Cardiomyopathy

About this section

Cellular components related to Peripartum Cardiomyopathy according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1muscle myosin complexGO:00058599.9MYH7, TTN
2sarcomereGO:00300179.8MYH7, TTN
3Z discGO:00300189.1MYH7, SCN5A, TTN
4lateral plasma membraneGO:00163289.0DRD2, SCN5A

Biological processes related to Peripartum Cardiomyopathy according to GeneCards Suite gene sharing:

(show all 8)
idNameGO IDScoreTop Affiliating Genes
1striated muscle contractionGO:00069419.9MYH7, TTN
2adenylate cyclase-activating adrenergic receptor signaling pathwayGO:00718809.8ADRB1, DRD2
3temperature homeostasisGO:00016599.7ADRB1, DRD2
4adult heart developmentGO:00075129.7MYH7, TTN
5muscle contractionGO:00069369.6MYH7, TTN
6muscle filament slidingGO:00300499.3MYH7, TTN
7cardiac muscle contractionGO:00600489.1MYH7, SCN5A, TTN
8regulation of heart rateGO:00020278.8DRD2, MYH7, SCN5A

Molecular functions related to Peripartum Cardiomyopathy according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1calmodulin bindingGO:00055169.2MYH7, SCN5A, TTN
2protein heterodimerization activityGO:00469828.9ADRB1, DRD2, MYH7

Sources for Peripartum Cardiomyopathy

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet